The technological firm Google announced today that its health issues unit will work together with the French pharmacist Sanofi to find new ways to control and treat diabetes.
Sanofi is one of the main world manufacturers of diabetes treatments and Google's health division (Google Life Sciences) develops small devices connected to the Internet to collect data on the disease, as well as software for the development of new treatments.
Google and Sanofi will seek new ways to store and analyze in real time information on glucose levels to better manage disease and avoid long -term complications such as heart attacks and cancer.
"We can see how the sensors, computer devices to bring positions and analytical tools can help people and doctors to obtain much more useful and easily more useful information about the evolution of their ailment and act based on it,"Google said in a statement.
Google Life Sciences began its work two years ago and is part of the measures to diversify the company beyond its search engine.
The division has agreements with other firms such as Novartis and Biogen.
Collaboration with Sanofi and other companies aims to combine knowledge about medicines with other knowledge in the area of medical devices, software and computer infrastructure.
The alliance with Novartis aims, for example, to produce on a large scale and carry out large studies with the supervision of the US authorities of some lenses that measure glucose levels in diabetics.
Google also announced this month that it will work with the firm Dexcom, which develops devices for glucose measurement, to develop a sensor to the size of a shiver that stores the data collected in "The Cloud".
Sanofi is the manufacturer of Lantus, the most used insulin in the world.
